IIM
OLMA icon

INTECH Investment Management’s Olema Pharmaceuticals OLMA Stock Holding History

INTECH Investment Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$392K Buy
26,266
+1,068
+4% +$23.8K ﹤0.01% 1458
2025
Q4 		$630K Buy
25,198
+11,631
+86% +$207K 0.01% 1380
2025
Q3 		$133K Sell
13,567
-25,042
-65% -$150K ﹤0.01% 2184
2025
Q2 		$164K Buy
38,609
+14,297
+59% +$63.7K ﹤0.01% 2154
2025
Q1 		$91.4K Buy
24,312
+6,570
+37% +$33K ﹤0.01% 2336
2024
Q4 		$103K Buy
17,742
+4,056
+30% +$40.5K ﹤0.01% 2205
2024
Q3 		$163K Buy
+13,686
New +$175K ﹤0.01% 1782

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

INTECH Investment Management's OLMA Position: Q1 2026 in Review

INTECH Investment Management increased its Olema Pharmaceuticals (OLMA) stake by 4.2% in Q1 2026, buying an estimated $23.8K and bringing the position to 26,266 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #1458.

INTECH Investment Management first reported a position in OLMA in Q3 2024 and has held it in 7 quarters since. The position peaked at $630K in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • INTECH Investment Management held 26,266 shares of Olema Pharmaceuticals worth $392K as of Q1 2026.
  • INTECH Investment Management bought 1,068 Olema Pharmaceuticals shares in Q1 2026, an estimated $23.8K.
  • Olema Pharmaceuticals made up ﹤0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1458 holding.
  • INTECH Investment Management first reported a position in Olema Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • INTECH Investment Management's Olema Pharmaceuticals position peaked at $630K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.